Perioperative antiplatelet therapy for abdominal surgery after stent
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at the best way to manage your blood-thinning medicine (antiplatelet therapy) around the time of abdominal surgery, if you have a coronary stent. The goal is to help reduce the risk of heart problems while keeping bleeding risks low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a coronary stent placed in your heart in the past.
- You need to be scheduled for abdominal surgery.
- You must be taking only one blood-thinning medicine (a single antiplatelet agent) — not two or a blood thinner.
- You cannot have had a blood clot inside your stent before (stent thrombosis).
- You must not have a very high risk of serious bleeding (for example, a CHADS2 score of 5 or higher).
- You must be at least 20 years old and able to consent to the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a structured (protocol-based) care plan before and around surgery improves outcomes for people taking blood-thinning medicines. It may help teams plan safer timing and monitoring to reduce complications around the operation.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Perioperative Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.